The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Mutations in Human ARF Exon 2 Disrupt Its Nucleolar Localization and Impair Its Ability to Block Nuclear Export of MDM2 and p53
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 1×
“These con-p53 protein by targeting p53 for degradation (Haupt et al., 1997; Kubbutat et al., 1997).”
BackgroundA cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751 · cited 1×
“…of human cancers, both familial andand link the human tumor-associated mutations in sporadic, at a frequency estimated to be close to thatARF with a functional alteration. of p53 locus (Kamb et al., 1994; Nobori et al., 1994; and recently compiled by Foulkes et al., 1997; Ruas and Peters, 1998).”
BackgroundDNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100
Zhang, Y., Xiong, Y., & Yarbrough, W. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81401-4 · Cited by 1,626
Self-citationTumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Pomerantz, J., Schreiber-Agus, N., Liégeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.-W., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81400-2 · Cited by 1,521
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
Zindy, F., Eischen, C. M., Randle, D. H., Kamijo, T., Cleveland, J. L., Sherr, C. J., & Roussel, M. F. (1998) · Genes & Development · doi:10.1101/gad.12.15.2424 · Cited by 1,245
Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2
Kamijo, T., Weber, J. D., Zambetti, G., Zindy, F., Roussel, M. F., & Sherr, C. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8292 · Cited by 899
Research works printed but not linked: 20
- Alcalay, 1998, The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein, Mol. Cell. Biol, 18, 1084, 10.1128/MCB.18.2.1084 · DOI · Paper page
- Bates, 1998, p14ARF links the tumor suppressors RB and p53, Nature, 395, 124, 10.1038/25867 · DOI · Paper page
- de Stanchina, 1998, E1A signaling to p53 involves the p19ARF tumor suppressor, Genes Dev, 12, 2434, 10.1101/gad.12.15.2434 · DOI · Paper page
- Dyck, 1994, A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein, Cell, 76, 333, 10.1016/0092-8674(94)90340-9 · DOI · Paper page
- Freedman, 1998, Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6, Mol. Cell. Biol, 18, 7288, 10.1128/MCB.18.12.7288 · DOI · Paper page
- Hsieh, 1999, RB regulates the stability and the apoptotic function of p53 via MDM2, Mol. Cell, 3, 181, 10.1016/S1097-2765(00)80309-3 · DOI · Paper page
- Lamorte, 1998, Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body, Proc. Natl. Acad. Sci. USA, 95, 4991, 10.1073/pnas.95.9.4991 · DOI
- Levine, 1997, p53, the cellular gatekeeper for growth and division, Cell, 88, 323, 10.1016/S0092-8674(00)81871-1 · DOI · Paper page
- Nobori, 1994, Deletion of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers, Nature, 368, 753, 10.1038/368753a0 · DOI · Paper page
- Palmero, 1998, p19ARF links the tumor suppressor p53 and Ras, Nature, 395, 125, 10.1038/25870 · DOI · Paper page
- Prives, 1998, Signaling to p53, Cell, 95, 5, 10.1016/S0092-8674(00)81774-2 · DOI · Paper page
- Quelle, 1995, Alterative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest, Cell, 83, 993, 10.1016/0092-8674(95)90214-7 · DOI · Paper page
- Quelle, 1997, Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16 INK4a but not by the alternative reading frame protein p19 ARF, Proc. Natl. Acad. Sci. USA, 94, 3436, 10.1073/pnas.94.2.669 · DOI
- Roth, 1998, Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein, EMBO J, 17, 554, 10.1093/emboj/17.2.554 · DOI · Paper page
- Ruas, 1998, The p16INK4a/CDK2A tumor suppresor and its relatives, Biochim. Biophys. Acta, 1378, F115
- Sherr, 1998, Tumor surveillance via the ARF-p53 pathway, Genes Dev, 12, 2984, 10.1101/gad.12.19.2984 · DOI · Paper page
- Stommel, 1999, A leucine-rich export signal in the p53 tetramerization domain, EMBO J, 18, 1660, 10.1093/emboj/18.6.1660 · DOI · Paper page
- Stott, 1998, The alternative product from the human CDK2A locus, p14ARF, participates in a regulatory feedback loop with p53 and MDM2, EMBO J, 17, 5001, 10.1093/emboj/17.17.5001 · DOI · Paper page
- Weis, 1994, Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells, Cell, 76, 345, 10.1016/0092-8674(94)90341-7 · DOI · Paper page
- Xiao, 1995, Interaction between the retinoblastima protein and the oncoprotein MDM2, Nature, 375, 694, 10.1038/375694a0 · DOI · Paper page
Cited by
Mechanisms Underlying Ubiquitination
Pickart, C. M. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.503 · Cited by 3,184
Boulon, S., Westman, B. J., Hutten, S., Boisvert, F.-M., & Lamond, A. I. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.024 · Cited by 1,103
Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53
Fang, S., Jensen, J. P., Ludwig, R. L., Vousden, K. H., & Weissman, A. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8945 · Cited by 1,044
HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation
Zhou, B. P., Liao, Y., Xia, W., Zou, Y., Spohn, B., & Hung, M.-C. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-973 · Cited by 951
Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis
Eischen, C. M., Weber, J. D., Roussel, M. F., Sherr, C. J., & Cleveland, J. L. (1999) · Genes & Development · doi:10.1101/gad.13.20.2658 · Cited by 819
Metadata
- Authors
- Zhang, Y., & Xiong, Y.
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 1999-05
- Volume
- 3
- Issue
- 5
- Pages
- 579-591
- ISSN
- 1097-2765 (ISSN-L)
- OpenAlex
- W1986256428
- Cited by
- 348
- References
- 13
- FWCI
- 19.31
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 5191 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mutations in Human ARF Exon 2 Disrupt Its Nucleolar Localization and Impair Its Ability to Block Nuclear Export of MDM2 and p53. https://app.cochat.ai/papers/10.1016/s1097-2765(00)80351-2
- The paper
- Zhang, Y., & Xiong, Y. (1999). Mutations in Human ARF Exon 2 Disrupt Its Nucleolar Localization and Impair Its Ability to Block Nuclear Export of MDM2 and p53. Molecular Cell. https://doi.org/10.1016/s1097-2765(00)80351-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
